Clinically, decreased plasma omentin levels have been consistently observed in patients with T2DM, while individual studies have also assessed parameters such as fasting glucose and the Homeostatic model assessment of insulin resistance (HOMA-IR) index [4,37]. This evidence concerns the gene ITLN1 and Insulin resistance.